Short-term treatment outcomes and safety of two representative brands of the fifth-generation silicone gel-filled breast implants in Korea
It is allegedly reported that the BellaGel ® SmoothFine (HansBiomed Co. Ltd., Seoul, Korea) and Motiva Ergonomix TM (Establishment Labs Holdings Inc., Alajuela, Costa Rica) are representative brands of a microtextured breast implant in Korea. We compared short-term safety outcomes between them. We e...
Gespeichert in:
| Veröffentlicht in: | Journal of plastic surgery and hand surgery 2021-12, Vol.55 (6), p.345-353 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 353 |
|---|---|
| container_issue | 6 |
| container_start_page | 345 |
| container_title | Journal of plastic surgery and hand surgery |
| container_volume | 55 |
| creator | Moon, Dong Seung Choi, Woo Sik Kim, Ho Chan Jeong, Jeong Pil Sung, Jung Youp Kim, Jae Hong |
| description | It is allegedly reported that the BellaGel
®
SmoothFine (HansBiomed Co. Ltd., Seoul, Korea) and Motiva Ergonomix
TM
(Establishment Labs Holdings Inc., Alajuela, Costa Rica) are representative brands of a microtextured breast implant in Korea. We compared short-term safety outcomes between them. We evaluated the patients who received breast augmentation using the BellaGel
®
SmoothFine (n = 264) or the Motiva Ergonomix™ (n = 76) for aesthetic purposes and those with available medical records. They were followed up during a mean period of 122.11 ± 95.37 (4-477) and 126.80 ± 116.29 (13-534) days in the corresponding order. Early seroma occurred at an incidence of 1.89 and 5.26% following breast augmentation using the BellaGel
®
SmoothFine and the Motiva Ergonomix
TM
, respectively. This difference reached statistical significance (p |
| doi_str_mv | 10.1080/2000656X.2021.1888744 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_33660572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2497097336</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-aa32f1255e32bab43058a272ed2c602f56383e25841c7de5c10a324518669da63</originalsourceid><addsrcrecordid>eNp9kc1OAyEUhYnRqFEfQcPSzVR-Bma60xj_ookLNXFHKHOxGGaoQDV9BZ9aaluXroB7v8O9OQehY0pGlLTkjBFCpJCvI0YYHdG2bZu63kL7y3olG1lvb-4F2kNHKb2XF-FjXhO5i_Y4l5KIhu2j76dpiLnKEHucI-jcw5BxmGcTekhYDx1O2kJe4GBx_go4wixCKpDO7hPwJBYk_TangK2zeVq9wQCxtMOAk_POhAHwG_jKOu-hKxLQKWPXz7wecsJuwPeh1A7RjtU-wdH6PEAv11fPl7fVw-PN3eXFQ2XK1rnSmjNLmRDA2URPak5Eq1nDoGNGEmaF5C0HJtqamqYDYSgpilrQVspxpyU_QKerf2cxfMwhZdW7ZMCXbSDMk2L1uCHjpnhUULFCTQwpRbBqFl2v40JRopZJqE0SapmEWidRdCfrEfNJD92fauN7Ac5XgBtsiL3-CtF3KuuFD9EWS41Liv8_4wcGPpnm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2497097336</pqid></control><display><type>article</type><title>Short-term treatment outcomes and safety of two representative brands of the fifth-generation silicone gel-filled breast implants in Korea</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Moon, Dong Seung ; Choi, Woo Sik ; Kim, Ho Chan ; Jeong, Jeong Pil ; Sung, Jung Youp ; Kim, Jae Hong</creator><creatorcontrib>Moon, Dong Seung ; Choi, Woo Sik ; Kim, Ho Chan ; Jeong, Jeong Pil ; Sung, Jung Youp ; Kim, Jae Hong</creatorcontrib><description>It is allegedly reported that the BellaGel
®
SmoothFine (HansBiomed Co. Ltd., Seoul, Korea) and Motiva Ergonomix
TM
(Establishment Labs Holdings Inc., Alajuela, Costa Rica) are representative brands of a microtextured breast implant in Korea. We compared short-term safety outcomes between them. We evaluated the patients who received breast augmentation using the BellaGel
®
SmoothFine (n = 264) or the Motiva Ergonomix™ (n = 76) for aesthetic purposes and those with available medical records. They were followed up during a mean period of 122.11 ± 95.37 (4-477) and 126.80 ± 116.29 (13-534) days in the corresponding order. Early seroma occurred at an incidence of 1.89 and 5.26% following breast augmentation using the BellaGel
®
SmoothFine and the Motiva Ergonomix
TM
, respectively. This difference reached statistical significance (p < 0.05). Of note, CC occurred at an incidence of 2.27 and 0.00% in the corresponding order. Cumulative incidences of postoperative complications depending on the type of breast implants showed no significant difference; statistical significance was analyzed using the log-rank test (χ
2
= 1.71, df = 1, p = 0.19). Cumulative survival of the breast implant is shown in Table 3; the Motiva Ergonomix™ showed a longer survival as compared with the BellaGel
®
SmoothFine (130.13 ± 13.70 vs. 120.45 ± 5.76 days). In conclusion, we describe short-term treatment outcomes and safety of an implant-based breast augmentation using two representative brands of the fifth-generation silicone gel-filled breast implants in Korean women.</description><identifier>ISSN: 2000-656X</identifier><identifier>EISSN: 2000-6764</identifier><identifier>DOI: 10.1080/2000656X.2021.1888744</identifier><identifier>PMID: 33660572</identifier><language>eng</language><publisher>Sweden: Taylor & Francis</publisher><subject>Breast ; Breast Implants ; esthetics ; Female ; Humans ; Mammaplasty - adverse effects ; operative ; reconstructive surgical procedures ; Republic of Korea ; Silicone Gels ; surgical procedures ; Treatment Outcome ; ultrasonography</subject><ispartof>Journal of plastic surgery and hand surgery, 2021-12, Vol.55 (6), p.345-353</ispartof><rights>2021 Acta Chirurgica Scandinavica Society 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-aa32f1255e32bab43058a272ed2c602f56383e25841c7de5c10a324518669da63</citedby><cites>FETCH-LOGICAL-c366t-aa32f1255e32bab43058a272ed2c602f56383e25841c7de5c10a324518669da63</cites><orcidid>0000-0002-7162-9944</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33660572$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moon, Dong Seung</creatorcontrib><creatorcontrib>Choi, Woo Sik</creatorcontrib><creatorcontrib>Kim, Ho Chan</creatorcontrib><creatorcontrib>Jeong, Jeong Pil</creatorcontrib><creatorcontrib>Sung, Jung Youp</creatorcontrib><creatorcontrib>Kim, Jae Hong</creatorcontrib><title>Short-term treatment outcomes and safety of two representative brands of the fifth-generation silicone gel-filled breast implants in Korea</title><title>Journal of plastic surgery and hand surgery</title><addtitle>J Plast Surg Hand Surg</addtitle><description>It is allegedly reported that the BellaGel
®
SmoothFine (HansBiomed Co. Ltd., Seoul, Korea) and Motiva Ergonomix
TM
(Establishment Labs Holdings Inc., Alajuela, Costa Rica) are representative brands of a microtextured breast implant in Korea. We compared short-term safety outcomes between them. We evaluated the patients who received breast augmentation using the BellaGel
®
SmoothFine (n = 264) or the Motiva Ergonomix™ (n = 76) for aesthetic purposes and those with available medical records. They were followed up during a mean period of 122.11 ± 95.37 (4-477) and 126.80 ± 116.29 (13-534) days in the corresponding order. Early seroma occurred at an incidence of 1.89 and 5.26% following breast augmentation using the BellaGel
®
SmoothFine and the Motiva Ergonomix
TM
, respectively. This difference reached statistical significance (p < 0.05). Of note, CC occurred at an incidence of 2.27 and 0.00% in the corresponding order. Cumulative incidences of postoperative complications depending on the type of breast implants showed no significant difference; statistical significance was analyzed using the log-rank test (χ
2
= 1.71, df = 1, p = 0.19). Cumulative survival of the breast implant is shown in Table 3; the Motiva Ergonomix™ showed a longer survival as compared with the BellaGel
®
SmoothFine (130.13 ± 13.70 vs. 120.45 ± 5.76 days). In conclusion, we describe short-term treatment outcomes and safety of an implant-based breast augmentation using two representative brands of the fifth-generation silicone gel-filled breast implants in Korean women.</description><subject>Breast</subject><subject>Breast Implants</subject><subject>esthetics</subject><subject>Female</subject><subject>Humans</subject><subject>Mammaplasty - adverse effects</subject><subject>operative</subject><subject>reconstructive surgical procedures</subject><subject>Republic of Korea</subject><subject>Silicone Gels</subject><subject>surgical procedures</subject><subject>Treatment Outcome</subject><subject>ultrasonography</subject><issn>2000-656X</issn><issn>2000-6764</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1OAyEUhYnRqFEfQcPSzVR-Bma60xj_ookLNXFHKHOxGGaoQDV9BZ9aaluXroB7v8O9OQehY0pGlLTkjBFCpJCvI0YYHdG2bZu63kL7y3olG1lvb-4F2kNHKb2XF-FjXhO5i_Y4l5KIhu2j76dpiLnKEHucI-jcw5BxmGcTekhYDx1O2kJe4GBx_go4wixCKpDO7hPwJBYk_TangK2zeVq9wQCxtMOAk_POhAHwG_jKOu-hKxLQKWPXz7wecsJuwPeh1A7RjtU-wdH6PEAv11fPl7fVw-PN3eXFQ2XK1rnSmjNLmRDA2URPak5Eq1nDoGNGEmaF5C0HJtqamqYDYSgpilrQVspxpyU_QKerf2cxfMwhZdW7ZMCXbSDMk2L1uCHjpnhUULFCTQwpRbBqFl2v40JRopZJqE0SapmEWidRdCfrEfNJD92fauN7Ac5XgBtsiL3-CtF3KuuFD9EWS41Liv8_4wcGPpnm</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Moon, Dong Seung</creator><creator>Choi, Woo Sik</creator><creator>Kim, Ho Chan</creator><creator>Jeong, Jeong Pil</creator><creator>Sung, Jung Youp</creator><creator>Kim, Jae Hong</creator><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7162-9944</orcidid></search><sort><creationdate>20211201</creationdate><title>Short-term treatment outcomes and safety of two representative brands of the fifth-generation silicone gel-filled breast implants in Korea</title><author>Moon, Dong Seung ; Choi, Woo Sik ; Kim, Ho Chan ; Jeong, Jeong Pil ; Sung, Jung Youp ; Kim, Jae Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-aa32f1255e32bab43058a272ed2c602f56383e25841c7de5c10a324518669da63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Breast</topic><topic>Breast Implants</topic><topic>esthetics</topic><topic>Female</topic><topic>Humans</topic><topic>Mammaplasty - adverse effects</topic><topic>operative</topic><topic>reconstructive surgical procedures</topic><topic>Republic of Korea</topic><topic>Silicone Gels</topic><topic>surgical procedures</topic><topic>Treatment Outcome</topic><topic>ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moon, Dong Seung</creatorcontrib><creatorcontrib>Choi, Woo Sik</creatorcontrib><creatorcontrib>Kim, Ho Chan</creatorcontrib><creatorcontrib>Jeong, Jeong Pil</creatorcontrib><creatorcontrib>Sung, Jung Youp</creatorcontrib><creatorcontrib>Kim, Jae Hong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of plastic surgery and hand surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moon, Dong Seung</au><au>Choi, Woo Sik</au><au>Kim, Ho Chan</au><au>Jeong, Jeong Pil</au><au>Sung, Jung Youp</au><au>Kim, Jae Hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Short-term treatment outcomes and safety of two representative brands of the fifth-generation silicone gel-filled breast implants in Korea</atitle><jtitle>Journal of plastic surgery and hand surgery</jtitle><addtitle>J Plast Surg Hand Surg</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>55</volume><issue>6</issue><spage>345</spage><epage>353</epage><pages>345-353</pages><issn>2000-656X</issn><eissn>2000-6764</eissn><abstract>It is allegedly reported that the BellaGel
®
SmoothFine (HansBiomed Co. Ltd., Seoul, Korea) and Motiva Ergonomix
TM
(Establishment Labs Holdings Inc., Alajuela, Costa Rica) are representative brands of a microtextured breast implant in Korea. We compared short-term safety outcomes between them. We evaluated the patients who received breast augmentation using the BellaGel
®
SmoothFine (n = 264) or the Motiva Ergonomix™ (n = 76) for aesthetic purposes and those with available medical records. They were followed up during a mean period of 122.11 ± 95.37 (4-477) and 126.80 ± 116.29 (13-534) days in the corresponding order. Early seroma occurred at an incidence of 1.89 and 5.26% following breast augmentation using the BellaGel
®
SmoothFine and the Motiva Ergonomix
TM
, respectively. This difference reached statistical significance (p < 0.05). Of note, CC occurred at an incidence of 2.27 and 0.00% in the corresponding order. Cumulative incidences of postoperative complications depending on the type of breast implants showed no significant difference; statistical significance was analyzed using the log-rank test (χ
2
= 1.71, df = 1, p = 0.19). Cumulative survival of the breast implant is shown in Table 3; the Motiva Ergonomix™ showed a longer survival as compared with the BellaGel
®
SmoothFine (130.13 ± 13.70 vs. 120.45 ± 5.76 days). In conclusion, we describe short-term treatment outcomes and safety of an implant-based breast augmentation using two representative brands of the fifth-generation silicone gel-filled breast implants in Korean women.</abstract><cop>Sweden</cop><pub>Taylor & Francis</pub><pmid>33660572</pmid><doi>10.1080/2000656X.2021.1888744</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-7162-9944</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2000-656X |
| ispartof | Journal of plastic surgery and hand surgery, 2021-12, Vol.55 (6), p.345-353 |
| issn | 2000-656X 2000-6764 |
| language | eng |
| recordid | cdi_pubmed_primary_33660572 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Breast Breast Implants esthetics Female Humans Mammaplasty - adverse effects operative reconstructive surgical procedures Republic of Korea Silicone Gels surgical procedures Treatment Outcome ultrasonography |
| title | Short-term treatment outcomes and safety of two representative brands of the fifth-generation silicone gel-filled breast implants in Korea |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A58%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Short-term%20treatment%20outcomes%20and%20safety%20of%20two%20representative%20brands%20of%20the%20fifth-generation%20silicone%20gel-filled%20breast%20implants%20in%20Korea&rft.jtitle=Journal%20of%20plastic%20surgery%20and%20hand%20surgery&rft.au=Moon,%20Dong%20Seung&rft.date=2021-12-01&rft.volume=55&rft.issue=6&rft.spage=345&rft.epage=353&rft.pages=345-353&rft.issn=2000-656X&rft.eissn=2000-6764&rft_id=info:doi/10.1080/2000656X.2021.1888744&rft_dat=%3Cproquest_pubme%3E2497097336%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2497097336&rft_id=info:pmid/33660572&rfr_iscdi=true |